Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CSBR
CHAMPIONS ONCOLOGY, INC.
NASDAQ
$4.93
▼ DOWN 1.79% (-0.09)

KEY STATISTICS

Market Cap$68.50 M
52w High$8.74
52w Low$4.83
Dividend Yield—
Frequency—
P/E-30.81
Volume5.14K
Shares Out.13.89M

COMPANY

LEADERSHIP

Robert Brainin
CHIEF EXECUTIVE
Robert Brainin

COMPENSATION 2026

Salary$233,333
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$0
Total$233,333

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 2, 2007
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
214

PRICE TARGET

Target High$12.00
Target Low$12.00
Target Median$12.00
Target Consensus$12.00

UPCOMING EARNINGS

DateSep 14, 2026
DayMonday
Rev. Est.$15.04M
SEP
14
MON

SPLIT RECORD

DATETYPERATIO
2015-08-12Reverse1:12

PRICE

$4.93 ▼ DOWN 1.79% (−$0.09)
OVERLAYS
$4.95$5.03$5.109:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM4.93

About Champions Oncology, Inc.

https://www.championsoncology.com ↗

Champions Oncology develops personalized cancer care solutions using Tumorgraft technology and offers translational and bioinformatics tools to aid drug development for pharma and biotech companies.

INDUSTRY

Biotechnology

A SERVICE CHAMPIONS ONCOLOGY, INC. IS KNOWN FOR

Radiopharmaceutical Services Platform

A new platform offering integrated radiopharmaceutical workflows using PDX models to assess biodistribution and therapeutic efficacy, aiding drug developers in evaluating radiolabeled agents in clinically relevant systems.

COMPETITORS

COMPETITOR
CRL COMPARE
ICLR COMPARE
IQV COMPARE
LH COMPARE
MEDP COMPARE

Revenue by Products

IconPRODUCTQ4-2025Q1-2026Q3-2026Q4-2026
Pharmacology Services$11.35M $13.23M ▲$16.18M ▲$27.72M ▲
Product and Service Other$831K $454K ▼$375K ▼$699K ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
13
LISTED HERE
3
RANKED BY POSITION SIZE
VTS.AX
0.00% · 230.0K
IWC
0.01% · 28.8K
PQ
PQSG
0.15% · 2.3K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
58.16%
HOLDERS
40
TOP 12 OF 40 · RANKED BY POSITION SIZE
Battery Management Corp.
2.4M sh · $13.92M
Battery Partners Ix, LLC
2.4M sh · $22.4M
Nea Management Company, LLC
1.7M sh · $9.85M
Vanguard Group Inc
334.6K sh · $2.31M
Tocqueville Asset Management L.P.
319.7K sh · $1.84M
Morgan Stanley
242.3K sh · $1.39M
Renaissance Technologies LLC
167.3K sh · $1.08M
Blackrock, Inc.
123.9K sh · $712.42K
Blackrock Inc.
116.1K sh · $600.09K
Mink Brook Asset Management LLC
80.3K sh · $554.91K
Geode Capital Management, LLC
77.2K sh · $443.86K
Act Capital Management, LLC
62.5K sh · $469K

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1

INSIDER TRADES

★
DIRECTOR, OFFICER: CEO
Brainin Robert Lawrence
Purchase · 150.0K shares
2025-07-16
★
DIRECTOR, OFFICER: CEO
Brainin Robert Lawrence
Purchase · 62.5K shares
2025-07-16
★
DIRECTOR, OFFICER: CEO
Brainin Robert Lawrence
Purchase · 225.0K shares
2025-07-16
★
DIRECTOR
Brainin Robert Lawrence
Purchase · 23.0K shares
2024-11-12

SECTORS PEERS

PEERPRICE
STTK$7.04COMPARE
ARTV$11.09COMPARE
IFRX$2.23COMPARE
ORMP$5.03COMPARE
STRO$20.45COMPARE
CNTB$2.23COMPARE
KLRS$4.03COMPARE
ATRA$9.20COMPARE